British Dragon Taldabol contains Tadalafil Citrate in oral tablet form, labeled at 20 mg per tablet. For tablet-based formulations, independent lab testing provides important verification of actual active substance content and helps evaluate how closely a batch matches its labeled dosage.
Below is the latest available lab test confirming the potency of Taldabol 20 mg, conducted by a trusted third-party laboratory.
Latest Lab Result (2026)
Janoshik Lab Report – 2026-03-23
- Product: Taldabol
- Active Substance: Tadalafil Citrate
- Manufacturer: British Dragon
- Labeled Dosage: 20 mg/tablet
- Result: 18.21 mg/tablet
- Laboratory: Janoshik
This lab test shows a measured content of 18.21 mg per tablet, which is below the labeled 20 mg dosage. The result indicates a moderate negative deviation from the stated amount.
Potency Analysis
- Labeled dosage: 20 mg
- Measured dosage: 18.21 mg
- Deviation: ~-8.9%
- Laboratory: Janoshik
The measured result shows a moderate deviation from the labeled dosage. For tablet formulations, this level of variance can occur depending on manufacturing and batch conditions.
About Taldabol (Tadalafil Citrate)
Tadalafil Citrate is commonly produced in oral tablet form, where consistent dosing is important for predictable formulation performance. Variations in tablet manufacturing processes can influence the final measured content per unit.
Independent lab testing provides transparency by confirming the actual potency of a specific batch.
Conclusion
The available lab test for British Dragon Taldabol 20 mg shows a measured dosage of 18.21 mg per tablet, which is below the labeled amount. This result indicates a moderate underdose in the tested batch.
As only one report is currently available, additional lab tests would help determine whether this result reflects a consistent pattern or an isolated batch variation.
Frequently Asked Questions
The available lab test shows 18.21 mg per tablet, which is below the labeled 20 mg dosage.
The measured result is approximately 9% below the labeled dosage.
The available report was conducted by Janoshik.
Currently, only one lab test is available. Additional reports would help evaluate consistency across batches.
